Reappraisal of the Therapies of Refractory Autoimmune Hemolytic Anemia in Systemic Lupus Erythematosus

NCT05057481 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Autoimmune Hemolytic Anemia
Systemic Lupus Erythematosus

Interventions

DRUG: Mycophenolate Mofetil 500mg
DRUG: Rituximab

Sponsor

Assiut University